Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
883.20    30.00 (3.52%)
Bid:
880.60
Ask:
881.40
Spread: 0.80 (0.091%)
Market Cap: £7.96b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

Director/PDMR Shareholding

16 Jun 2022 15:38

RNS Number : 1959P
Sage Group PLC
16 June 2022
 

DIRECTOR/ PDMR SHAREHOLDING

 

16 June 2022

 

 

The Sage Group plc. ("Sage")

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities

 

This notification relates to transactions notified in accordance with Article 19 of the UK Market Abuse Regulation.

 

Sage announces that on 14 June 2022 it granted options (the "Options") over a total of 1,628,085 ordinary shares of 14/77 pence each to 2,012 employees, pursuant to The Sage Save and Share Plan (the "Plan").

 

The invitation to join the Plan was made available to all employees of Sage globally, who were employed on or before 9 May 2022. Employees are limited to a maximum saving of £500 per month (or equivalent in local currency) over the period of the Plan. The grant of Options amounts to 0.1479% of Sage's issued share capital as at 14 June 2022. The exercise of Options on maturity is not dependent upon performance criteria.

 

The Options for UK participants are exercisable between 1 August 2025 and 31 January 2026 with the exercise price set at a 20% discount to the average middle market quotation of the three dealing days prior to the launch of the Plan on 19 May 2022 and is 533 pence per ordinary share. 

The Options for US Participants* are exercisable between 1 August 2024 and 31 August 2024 with the exercise price set at a 15% discount to the average middle market quotation of the three dealing days prior to the grant date of the Plan on 14 June 2022 and is 533 pence per ordinary share.

The following PDMRs have applied to participate in the Plan and are included in the totals above as follows:

 

PDMRs

Participating country

Number of Options granted

Option price per ordinary share

Amanda Cusdin

UK

1,013

533 pence

Walid Abu-Hadba*

US

2,471

533 pence

 

 

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Amanda Cusdin

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief People Officer

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

The Sage Group plc.

b)

 

LEI

 

2138005RN5XYLTF8G138

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

ISIN: GB00B8C3BL03

b)

 

Nature of the transaction

 

 

Grant of Options over ordinary shares under The Sage Save and Share Plan, exercisable between 1 August 2025 and 31 January 2026

c)

 

Price(s) and volume(s)

Price

Volume

Nil

1,013

 

 

d)

 

Aggregated information

N/A - single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

14 June 2022

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Walid Abu-Hadba

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Product Officer

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

The Sage Group plc.

b)

 

LEI

 

2138005RN5XYLTF8G138

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

ISIN: GB00B8C3BL03

b)

 

Nature of the transaction

 

 

Grant of Options over ordinary shares under The Sage Save and Share Plan, exercisable between 1 August 2024 and 31 August 2024

c)

 

Price(s) and volume(s)

Price

Volume

Nil

2,471

 

 

d)

 

Aggregated information

N/A - single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

14 June 2022

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

Name of contact:

Mohor Roy

Telephone number of contact:

+44(0) 203 810 7200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFMITMTJBBRT
Date   Source Headline
29th May 20262:15 pmRNSTotal Voting Rights
28th May 20266:25 pmRNSTransaction in Own Shares
28th May 20263:15 pmRNSDirector/PDMR Shareholding
27th May 20266:25 pmRNSTransaction in Own Shares
27th May 202611:05 amRNSDirector/PDMR Shareholding
26th May 20266:25 pmRNSTransaction in Own Shares
22nd May 20266:25 pmRNSTransaction in Own Shares
22nd May 202611:00 amRNSDirector/PDMR Shareholding
21st May 20266:25 pmRNSTransaction in Own Shares
21st May 20267:00 amRNSResults for the six months to 31 March 2026
20th May 20266:25 pmRNSTransaction in Own Shares
18th May 20266:25 pmRNSTransaction in Own Shares
15th May 20266:25 pmRNSTransaction in Own Shares
14th May 20266:25 pmRNSTransaction in Own Shares
13th May 20266:25 pmRNSTransaction in Own Shares
12th May 20266:25 pmRNSTransaction in Own Shares
11th May 20266:25 pmRNSTransaction in Own Shares
8th May 20266:25 pmRNSTransaction in Own Shares
7th May 20266:25 pmRNSTransaction in Own Shares
6th May 20266:25 pmRNSTransaction in Own Shares
5th May 20266:25 pmRNSTransaction in Own Shares
1st May 20266:25 pmRNSTransaction in Own Shares
30th Apr 20266:25 pmRNSTransaction in Own Shares
30th Apr 20264:15 pmRNSTotal Voting Rights
29th Apr 20266:25 pmRNSTransaction in Own Shares
28th Apr 20266:25 pmRNSTransaction in Own Shares
27th Apr 20266:25 pmRNSTransaction in Own Shares
24th Apr 20266:25 pmRNSTransaction in Own Shares
23rd Apr 20266:25 pmRNSTransaction in Own Shares
22nd Apr 20266:25 pmRNSTransaction in Own Shares
21st Apr 20266:25 pmRNSTransaction in Own Shares
14th Apr 20266:25 pmRNSHolding(s) in Company
14th Apr 20266:25 pmRNSTransaction in Own Shares
13th Apr 20266:25 pmRNSTransaction in Own Shares
10th Apr 20266:25 pmRNSTransaction in Own Shares
9th Apr 20266:25 pmRNSTransaction in Own Shares
8th Apr 20266:25 pmRNSTransaction in Own Shares
31st Mar 20263:45 pmRNSTotal Voting Rights
19th Mar 20266:25 pmRNSTransaction in Own Shares
18th Mar 20266:25 pmRNSTransaction in Own Shares
17th Mar 20266:25 pmRNSTransaction in Own Shares
17th Mar 20266:00 pmRNSDirector/PDMR Shareholding
16th Mar 20266:25 pmRNSTransaction in Own Shares
13th Mar 20266:25 pmRNSTransaction in Own Shares
12th Mar 20266:25 pmRNSTransaction in Own Shares
11th Mar 20263:47 pmRNSHolding(s) in Company
11th Mar 20263:47 pmRNSHolding(s) in Company
10th Mar 20266:25 pmRNSTransaction in Own Shares
10th Mar 20264:36 pmRNSDirector/PDMR Shareholding
10th Mar 20264:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.